Quest Diagnostics (DGX) Shares Repurchased (2016 - 2024)
Historic Shares Repurchased for Quest Diagnostics (DGX) over the last 16 years, with Q4 2024 value amounting to $151.0 million.
- Quest Diagnostics' Shares Repurchased fell 4509.09% to $151.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $426.0 million, marking a year-over-year increase of 5490.91%. This contributed to the annual value of $151.0 million for FY2024, which is 4509.09% down from last year.
- Quest Diagnostics' Shares Repurchased amounted to $151.0 million in Q4 2024, which was down 4509.09% from $275.0 million recorded in Q4 2023.
- Quest Diagnostics' Shares Repurchased's 5-year high stood at $1.5 billion during Q2 2021, with a 5-year trough of $75.0 million in Q1 2020.
- Its 5-year average for Shares Repurchased is $396.2 million, with a median of $289.0 million in 2021.
- In the last 5 years, Quest Diagnostics' Shares Repurchased soared by 44666.67% in 2021 and then crashed by 8666.67% in 2022.
- Over the past 5 years, Quest Diagnostics' Shares Repurchased (Quarter) stood at $250.0 million in 2020, then grew by 15.6% to $289.0 million in 2021, then skyrocketed by 59.52% to $461.0 million in 2022, then plummeted by 40.35% to $275.0 million in 2023, then crashed by 45.09% to $151.0 million in 2024.
- Its Shares Repurchased was $151.0 million in Q4 2024, compared to $275.0 million in Q4 2023 and $461.0 million in Q4 2022.